CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to Navitoclax
M. Neault, C.-E. Lebert-Ghali, M. Fournier, C. Capdevielle, E. A. R. Garfinkle, A. Obermayer, A. Cotton, K. Boulay, C. Sawchyn, K. H. Nguyen, B. Assaf, F. E. Mercier, J.-S. Delisle, E. A. Drobetsky, L. Hulea, , F. A. Mallette
This study identifies GLIS2 as a driver of pediatric AMKL and shows its sensitivity to navitoclax, offering a potential therapeutic strategy.
Cell Reports · Sep 1, 2023Peer-reviewedCancer Biology